WallStreetZenWallStreetZen

NASDAQ: BCDA
Biocardia Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for BCDA

Based on 1 analyst offering 12 month price targets for Biocardia Inc.
Min Forecast
$4.00+961.01%
Avg Forecast
$4.00+961.01%
Max Forecast
$4.00+961.01%

Should I buy or sell BCDA stock?

Based on 1 analyst offering ratings for Biocardia Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BCDA stock forecasts and price targets.

BCDA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-14

1 of 1

Forecast return on equity

Is BCDA forecast to generate an efficient return?

Forecast return on assets

Is BCDA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BCDA revenue forecast

What is BCDA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$700.0k+46.75%
Avg 2 year Forecast
$700.0k+46.75%
Avg 3 year Forecast
$5.7M+1,094.97%
BCDA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BCDA revenue growth forecast

How is BCDA forecast to perform vs Biotechnology companies and vs the US market?
Company
116.89%
Industry
37.96%
Market
10.23%
BCDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BCDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BCDA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BCDA$0.38$4.00+961.01%Buy
MBRX$4.52$35.00+673.65%Strong Buy
GRTX$0.19N/AN/A
ELAB$0.59N/AN/A
CMMB$0.70$7.00+900.00%Strong Buy
View Top Biotech Stocks

Biocardia Stock Forecast FAQ

Is Biocardia Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BCDA) stock is to Buy BCDA stock.

Out of 1 analyst, 0 (0%) are recommending BCDA as a Strong Buy, 1 (100%) are recommending BCDA as a Buy, 0 (0%) are recommending BCDA as a Hold, 0 (0%) are recommending BCDA as a Sell, and 0 (0%) are recommending BCDA as a Strong Sell.

If you're new to stock investing, here's how to buy Biocardia stock.

What is BCDA's revenue growth forecast for 2024-2026?

(NASDAQ: BCDA) Biocardia's forecast annual revenue growth rate of 116.89% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Biocardia's revenue in 2024 is $477,000.On average, 1 Wall Street analysts forecast BCDA's revenue for 2024 to be $18,712,779, with the lowest BCDA revenue forecast at $18,712,779, and the highest BCDA revenue forecast at $18,712,779. On average, 1 Wall Street analysts forecast BCDA's revenue for 2025 to be $18,712,779, with the lowest BCDA revenue forecast at $18,712,779, and the highest BCDA revenue forecast at $18,712,779.

In 2026, BCDA is forecast to generate $152,375,489 in revenue, with the lowest revenue forecast at $152,375,489 and the highest revenue forecast at $152,375,489.

What is BCDA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BCDA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is BCDA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BCDA price target, the average BCDA price target is $4.00, with the highest BCDA stock price forecast at $4.00 and the lowest BCDA stock price forecast at $4.00.

The Wall Street analyst predicted that Biocardia's share price could reach $4.00 by Nov 14, 2024. The average Biocardia stock price prediction forecasts a potential upside of 961.01% from the current BCDA share price of $0.38.

What is BCDA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BCDA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.